Continue to site >
Trending ETFs
You have successfully subscribed to Advisor Access. Thank you!
Help us personalize your experience.
Which type of investor describes you best?
Help us personalize your experience.
What is your AUM?
Knowing your investable assets will help us build and prioritize features that will suit your investment needs.

Congratulations on personalizing your experience.

Email is verified. Thank you!

Name

As of 04/30/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Health Sciences Trust

JAFMX | Fund

$24.64

$263 M

0.00%

1.01%

Vitals

YTD Return

2.2%

1 yr return

N/A

3 Yr Avg Return

N/A

5 Yr Avg Return

N/A

Net Assets

$263 M

Holdings in Top 10

42.3%

52 WEEK LOW AND HIGH

$24.7
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 1.01%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover N/A

Redemption Fee N/A

Min Investment

Standard (Taxable)

N/A

IRA

N/A

Fund Classification

Fund Type

Open End Mutual Fund

Name

As of 04/30/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Health Sciences Trust

JAFMX | Fund

$24.64

$263 M

0.00%

1.01%

JAFMX - Profile

Distributions

  • YTD Total Return 2.2%
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio N/A
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annual

Fund Details

  • Legal Name
    Health Sciences Trust
  • Fund Family Name
    John Hancock Group of Funds
  • Inception Date
    Apr 29, 2005
  • Shares Outstanding
    N/A
  • Share Class
    Other
  • Currency
    USD
  • Domiciled Country
    US

Fund Description

Under normal market conditions, the fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in common stocks of companies engaged, at the time of investment, in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively, “health sciences”). (The fund will provide written notice to shareholders at least 60 days prior to a change in its 80% investment policy.)  While the fund may invest in companies of any size, the majority of its assets are expected to be invested in large- and mid-cap companies.The subadvisor’s portfolio managers divide the health sciences sector into four main areas: pharmaceutical companies, health care services companies, medical products and devices providers, and biotechnology firms. Their allocation among these four areas will vary depending on the relative potential within each area and the outlook for the overall health sciences sector. While most assets will be invested in U.S. common stocks, the fund may purchase other securities, including foreign securities, in keeping with its investment objective.The fund concentrates its investments (invests more than 25% of its total assets) in securities of companies in the health sciences sector, a comparatively narrow segment of the economy, and therefore may experience greater volatility than funds investing in a broader range of industries.In managing the fund, the subadvisor uses a fundamental, bottom-up analysis that seeks to identify high quality companies and the most compelling investment opportunities. In general, the fund will follow a growth investment strategy, seeking companies whose earnings are expected to grow faster than inflation and the economy in general. When stock valuations seem unusually high, however, a “value” approach, which gives preference to seemingly undervalued companies, may also be emphasized.The fund may invest up to 35% of its total assets in foreign securities (including emerging market securities) and may have exposure to foreign currencies through its investment in these securities, its direct holdings of foreign currencies or through its use of foreign currency exchange contracts for the purchase or sale of a fixed quantity of a foreign currency at a future date.In pursuing its investment objective, the fund’s management has the discretion to purchase some securities that do not meet its normal investment criteria, as described above, when it perceives an opportunity for substantial appreciation. These  situations might arise when the fund’s management believes a security could increase in value for a variety of reasons including a change in management, an extraordinary corporate event, or a new product introduction or innovation or a favorable competitive development.The fund may sell securities for a variety of reasons including to realize gains, limit losses or redeploy assets into more promising opportunities.Use of Hedging and Other Strategic Transactions. The fund is authorized to use all of the various investment strategies referred to under “Additional Information About the Funds’ Principal Risks — Hedging, derivatives and other strategic transactions risk” including entering into option transactions.
Read More

JAFMX - Performance

Return Ranking - Trailing

Period JAFMX Return Category Return Low Category Return High Rank in Category (%)
YTD 2.2% N/A N/A N/A
1 Yr N/A N/A N/A N/A
3 Yr N/A* N/A N/A N/A
5 Yr N/A* N/A N/A N/A
10 Yr N/A* N/A N/A N/A

* Annualized

Return Ranking - Calendar

Period JAFMX Return Category Return Low Category Return High Rank in Category (%)
2023 N/A N/A N/A N/A
2022 N/A N/A N/A N/A
2021 N/A N/A N/A N/A
2020 N/A N/A N/A N/A
2019 N/A N/A N/A N/A

Total Return Ranking - Trailing

Period JAFMX Return Category Return Low Category Return High Rank in Category (%)
YTD 2.2% N/A N/A N/A
1 Yr N/A N/A N/A N/A
3 Yr N/A* N/A N/A N/A
5 Yr N/A* N/A N/A N/A
10 Yr N/A* N/A N/A N/A

* Annualized

Total Return Ranking - Calendar

Period JAFMX Return Category Return Low Category Return High Rank in Category (%)
2023 N/A N/A N/A N/A
2022 N/A N/A N/A N/A
2021 N/A N/A N/A N/A
2020 N/A N/A N/A N/A
2019 N/A N/A N/A N/A

NAV & Total Return History

JAFMX - Holdings

Concentration Analysis

JAFMX Category Low Category High JAFMX % Rank
Net Assets 263 M N/A N/A N/A
Number of Holdings 188 N/A N/A N/A
Net Assets in Top 10 111 M N/A N/A N/A
Weighting of Top 10 42.35% N/A N/A N/A

Top 10 Holdings

  1. UNITEDHEALTH GROUP INC COMMON STOCK USD.01 8.04%
  2. ELI LILLY and CO COMMON STOCK 8.00%
  3. THERMO FISHER SCIENTIFIC INC COMMON STOCK USD1.0 4.72%
  4. INTUITIVE SURGICAL INC COMMON STOCK USD.001 3.80%
  5. ELEVANCE HEALTH INC COMMON STOCK USD.01 3.52%
  6. MERCK and CO INC COMMON STOCK USD.5 3.50%
  7. STRYKER CORP COMMON STOCK USD.1 3.25%
  8. DANAHER CORP COMMON STOCK USD.01 2.78%
  9. VERTEX PHARMACEUTICALS INC COMMON STOCK USD.01 2.72%
  10. ASTRAZENECA PLC ADR 1.99%

Asset Allocation

Weighting Return Low Return High JAFMX % Rank
Stocks 		97.23% N/A N/A N/A
Cash 		2.32% N/A N/A N/A
Preferred Stocks 		0.45% N/A N/A N/A
Other 		0.00% N/A N/A N/A
Convertible Bonds 		0.00% N/A N/A N/A
Bonds 		0.00% N/A N/A N/A

Stock Sector Breakdown

Weighting Return Low Return High JAFMX % Rank
Utilities 		0.00% N/A N/A N/A
Technology 		0.00% N/A N/A N/A
Real Estate 		0.00% N/A N/A N/A
Industrials 		0.00% N/A N/A N/A
Healthcare 		0.00% N/A N/A N/A
Financial Services 		0.00% N/A N/A N/A
Energy 		0.00% N/A N/A N/A
Communication Services 		0.00% N/A N/A N/A
Consumer Defense 		0.00% N/A N/A N/A
Consumer Cyclical 		0.00% N/A N/A N/A
Basic Materials 		0.00% N/A N/A N/A

Stock Geographic Breakdown

Weighting Return Low Return High JAFMX % Rank
US 		96.25% N/A N/A N/A
Non US 		0.98% N/A N/A N/A

JAFMX - Expenses

Operational Fees

JAFMX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.01% N/A N/A N/A
Management Fee 0.92% N/A N/A N/A
12b-1 Fee N/A N/A N/A N/A
Administrative Fee N/A N/A N/A N/A

Sales Fees

JAFMX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A N/A N/A N/A
Deferred Load N/A N/A N/A N/A

Trading Fees

JAFMX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A N/A N/A N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

JAFMX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A N/A N/A N/A

JAFMX - Distributions

Dividend Yield Analysis

JAFMX Category Low Category High JAFMX % Rank
Dividend Yield 0.00% N/A N/A N/A

Dividend Distribution Analysis

JAFMX Category Low Category High Category Mod
Dividend Distribution Frequency Annual

Net Income Ratio Analysis

JAFMX Category Low Category High JAFMX % Rank
Net Income Ratio N/A N/A N/A N/A

Capital Gain Distribution Analysis

JAFMX Category Low Category High Capital Mode
Capital Gain Distribution Frequency

Distributions History

View More +

JAFMX - Fund Manager Analysis

Tenure Analysis

Category Low Category High Category Average Category Mode
N/A N/A N/A N/A

Advertisement

×

Wait! Do you know all the important aspects of mutual funds?

×

Free Advisor Access newsletter emailed to you.

Receive free and exclusive email updates for financial advisors about best performers, news, CE accredited webcasts and more.

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Disclaimer: By registering, you agree to share your data with MutualFunds.com and opt-in to receiving occasional communications about projects and events. The contents of this form are subject to the MutualFunds.com Privacy Policy. You can unsubscribe at any time.